{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:19Z","timestamp":1787003599446,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81602913"],"award-info":[{"award-number":["81602913"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81670155"],"award-info":[{"award-number":["81670155"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"China Postdoctoral Science Foundation funded project","award":["2019M650118"],"award-info":[{"award-number":["2019M650118"]}]},{"name":"Nanjing Medical Science and Technology Development Foundation","award":["QRX17164"],"award-info":[{"award-number":["QRX17164"]}]},{"name":"Special Fund for Health Science and Technology Development in Nanjing","award":["JQX19008"],"award-info":[{"award-number":["JQX19008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tumor lysis syndrome (TLS) is a common and fatal complication of childhood hematologic malignancies, especially acute lymphoblastic leukemia (ALL). The clinical features, therapeutic regimens, and outcomes of TLS have not been comprehensively analyzed in Chinese children with ALL. A total of 5537 children with ALL were recruited from the Chinese Children\u2019s Cancer Group, including 79 diagnosed with TLS. The clinical characteristics, treatment regimens, and survival of TLS patients were analyzed. Age distribution of children with TLS was remarkably different from those without TLS. White blood cells (WBC) count\u2009\u2265\u200950\u2009\u00d7\u200910\n                    <jats:sup>9<\/jats:sup>\n                    \/L was associated with a higher risk of TLS [odds ratio (OR)\u2009=\u20092.6, 95% CI\u2009=\u20091.6\u20134.5]. The incidence of T-ALL in TLS children was significantly higher than that in non-TLS controls (OR\u2009=\u20094.7, 95% CI\u2009=\u20092.6\u20138.8). Hyperphosphatemia and hypocalcemia were more common in TLS children with hyperleukocytosis (OR\u2009=\u20092.6, 95% CI\u2009=\u20091.0\u20136.9 and OR\u2009=\u20095.4, 95% CI\u2009=\u20092.0\u201314.2, respectively). Significant differences in levels of potassium (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.004), calcium (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001), phosphorus (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001) and uric acid (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001) were observed between groups of TLS patients with and without increased creatinine. Laboratory analysis showed that older age was associated with a higher level of creatinine. Calcium level was notably lower in males. WBC count, lactate dehydrogenase, and creatinine levels were significantly higher in T-ALL subgroup, whereas procalcitonin level was higher in B-ALL children. Older age, infant, a higher level of WBC and T-ALL were risk factors TLS occurrence. Hyperleukocytosis has an impact on the severity of TLS, while renal injury may be an important feature in the process of TLS.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-88912-2","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T06:06:43Z","timestamp":1620281203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"11","author":[{"given":"Yao","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Kong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changda","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianmin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"issue":"14","key":"88912_CR1","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","volume":"30","author":"SP Hunger","year":"2012","unstructured":"Hunger, S. P. et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children\u2019s oncology group. J. Clin. Oncol. 30(14), 1663\u20131669 (2012).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"88912_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pcl.2014.09.004","volume":"62","author":"D Bhojwani","year":"2015","unstructured":"Bhojwani, D., Yang, J. J. & Pui, C. H. Biology of childhood acute lymphoblastic leukemia. Pediatr. Clin. North Am. 62(1), 47\u201360 (2015).","journal-title":"Pediatr. Clin. North Am."},{"issue":"1","key":"88912_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3324\/haematol.2015.131680","volume":"101","author":"T Oskarsson","year":"2016","unstructured":"Oskarsson, T. et al. Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome. Haematologica 101(1), 68\u201376 (2016).","journal-title":"Haematologica"},{"issue":"8","key":"88912_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/PEC.0000000000000195","volume":"30","author":"RA Burns","year":"2014","unstructured":"Burns, R. A., Topoz, I. & Reynolds, S. L. Tumor lysis syndrome: risk factors, diagnosis, and management. Pediatr. Emerg. Care 30(8), 571\u2013576 (2014) (quiz 577\u20139).","journal-title":"Pediatr. Emerg. Care"},{"issue":"12","key":"88912_CR5","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1634\/theoncologist.2017-0147","volume":"22","author":"U Durani","year":"2017","unstructured":"Durani, U., Shah, N. D. & Go, R. S. In-hospital outcomes of tumor lysis syndrome: a population-based study using the national inpatient sample. Oncologist 22(12), 1506\u20131509 (2017).","journal-title":"Oncologist"},{"issue":"2","key":"88912_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1586\/17474086.2016.1127156","volume":"9","author":"M Criscuolo","year":"2016","unstructured":"Criscuolo, M., Fianchi, L., Dragonetti, G. & Pagano, L. Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency. Expert Rev. Hematol. 9(2), 197\u2013208 (2016).","journal-title":"Expert Rev. Hematol."},{"issue":"19","key":"88912_CR7","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1056\/NEJMra0904569","volume":"364","author":"SC Howard","year":"2011","unstructured":"Howard, S. C., Jones, D. P. & Pui, C. H. The tumor lysis syndrome. N. Engl. J. Med. 364(19), 1844\u20131854 (2011).","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"88912_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1365-2141.2010.08143.x","volume":"149","author":"MS Cairo","year":"2010","unstructured":"Cairo, M. S., Coiffier, B., Reiter, A., Younes, A. & T.L.S.E. Panel. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br. J. Haematol. 149(4), 578\u2013586 (2010).","journal-title":"Br. J. Haematol."},{"issue":"16","key":"88912_CR9","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","volume":"26","author":"B Coiffier","year":"2008","unstructured":"Coiffier, B., Altman, A., Pui, C. H., Younes, A. & Cairo, M. S. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J. Clin. Oncol. 26(16), 2767\u20132778 (2008).","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"88912_CR10","first-page":"1625","volume":"68","author":"F Saeed","year":"2018","unstructured":"Saeed, F., Ali, M. S., Ashraf, M. S., Vadsaria, K. & Siddiqui, D. E. Tumour lysis syndrome in children with haematological cancers: experience at a tertiary care hospital in Karachi. J. Pak. Med. Assoc. 68(11), 1625\u20131630 (2018).","journal-title":"J. Pak. Med. Assoc."},{"issue":"12","key":"88912_CR11","doi-asserted-by":"publisher","first-page":"e27401","DOI":"10.1002\/pbc.27401","volume":"65","author":"KG Gopakumar","year":"2018","unstructured":"Gopakumar, K. G. et al. Risk-based management strategy and outcomes of tumor lysis syndrome in children with leukemia\/lymphoma: analysis from a resource-limited setting. Pediatr. Blood Cancer 65(12), e27401 (2018).","journal-title":"Pediatr. Blood Cancer"},{"issue":"6","key":"88912_CR12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/archdischild-2018-316181","volume":"104","author":"J Cai","year":"2019","unstructured":"Cai, J. et al. Treatment abandonment in childhood acute lymphoblastic leukaemia in China: a retrospective cohort study of the Chinese Children\u2019s Cancer Group. Arch. Dis. Child. 104(6), 522\u2013529 (2019).","journal-title":"Arch. Dis. Child."},{"key":"88912_CR13","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/jamaoncol.2019.5868","volume":"6","author":"S Shen","year":"2020","unstructured":"Shen, S. et al. Effect of dasatinib versus imatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: a randomized clinical trial. JAMA Oncol. 6, 358 (2020).","journal-title":"JAMA Oncol."},{"key":"88912_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/hon.2668","volume":"37","author":"B Rahmani","year":"2019","unstructured":"Rahmani, B. et al. Current understanding of tumor lysis syndrome. Hematol. Oncol. 37, 537\u2013547 (2019).","journal-title":"Hematol. Oncol."},{"issue":"1","key":"88912_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","volume":"127","author":"MS Cairo","year":"2004","unstructured":"Cairo, M. S. & Bishop, M. Tumour lysis syndrome: new therapeutic strategies and classification. Br. J. Haematol. 127(1), 3\u201311 (2004).","journal-title":"Br. J. Haematol."},{"issue":"4","key":"88912_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hon.995","volume":"29","author":"YH Ahn","year":"2011","unstructured":"Ahn, Y. H. et al. Tumour lysis syndrome in children: experience of last decade. Hematol. Oncol. 29(4), 196\u2013201 (2011).","journal-title":"Hematol. Oncol."},{"issue":"1","key":"88912_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/pbc.21478","volume":"51","author":"S Abdullah","year":"2008","unstructured":"Abdullah, S. et al. Sevelamer hydrochloride: a novel treatment of hyperphosphatemia associated with tumor lysis syndrome in children. Pediatr. Blood Cancer 51(1), 59\u201361 (2008).","journal-title":"Pediatr. Blood Cancer"},{"key":"88912_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12878-018-0117-0","volume":"18","author":"H Micho","year":"2018","unstructured":"Micho, H., Mohammed, Y., Hailu, D. & Genet, S. Evaluation and characterization of tumor lysis syndrome before and after chemotherapy among pediatric oncology patients in Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. BMC Hematol. 18, 22 (2018).","journal-title":"BMC Hematol."},{"issue":"4","key":"88912_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/bjh.12415","volume":"162","author":"M Darmon","year":"2013","unstructured":"Darmon, M. et al. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Reanimation Respiratoire et Onco-Hematologique. Br. J. Haematol. 162(4), 489\u2013497 (2013).","journal-title":"Br. J. Haematol."},{"issue":"1","key":"88912_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1053\/j.ackd.2013.07.001","volume":"21","author":"FP Wilson","year":"2014","unstructured":"Wilson, F. P. & Berns, J. S. Tumor lysis syndrome: new challenges and recent advances. Adv. Chronic Kidney Dis. 21(1), 18\u201326 (2014).","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"2","key":"88912_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/17474086.2017.1270754","volume":"10","author":"S Giammarco","year":"2017","unstructured":"Giammarco, S. et al. Hyperleukocytosis and leukostasis: management of a medical emergency. Expert Rev. Hematol. 10(2), 147\u2013154 (2017).","journal-title":"Expert Rev. Hematol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88912-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88912-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88912-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:46:36Z","timestamp":1670035596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88912-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88912"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88912-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]},"assertion":[{"value":"16 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9656"}}